Yuko Ishida

Dr. Yuko Ishida

orcid

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
YIYuko Ishida
Yuko Ishida
YKYumi Kuninaka
Yumi Kuninaka
Naofumi MukaidaNaofumi Mukaida
Naofumi Mukaida
TKToshikazu Kondo
Toshikazu Kondo
Fibrosis and structural remodeling of the lung tissue can significantly impair lung function, often with fatal consequences. The etiology of pulmonary fibrosis (PF) is diverse and includes different triggers such as allergens, chemicals, radiation, and environmental particles. However, the cause of idiopathic PF (IPF), one of the most common forms of PF, remains unknown. Experimental models have been developed to study the mechanisms of PF, and the murine bleomycin (BLM) model has received the most attention. Epithelial injury, inflammation, epithelial–mesenchymal transition (EMT), myofibroblast activation, and repeated tissue injury are important initiators of fibrosis. In this review, we examined the common mechanisms of lung wound-healing responses after BLM-induced lung injury as well as the pathogenesis of the most common PF. A three-stage model of wound repair involving injury, inflammation, and repair is outlined. Dysregulation of one or more of these three phases has been reported in many cases of PF. We reviewed the literature investigating PF pathogenesis, and the role of cytokines, chemokines, growth factors, and matrix feeding in an animal model of BLM-induced PF.

25 November 2022 in Scientific Reports
Verified
Journal Article
Open access
PDF file
YKYumi Kuninaka
Yumi Kuninaka
YIYuko Ishida
Yuko Ishida
AIAkiko Ishigami
Akiko Ishigami
MNMizuho Nosaka
Mizuho Nosaka
JMJumpei Matsuki
Jumpei Matsuki
TKToshikazu Kondo
Toshikazu Kondo
We investigated the dynamics of the gene expression of M1 and M2 macrophage markers during skin wound healing in mice. Expression of M1-macrophage markers, such as Il12a, Tnf, Il6, Il1b, and Nos2 was upregulated after wounding and peaked at 1 or 3 days after injury, and that of M2-macrophage markers such as Mrc1, Cd163, Ccl17, Arg, and Tgfb1, peaked at 6 days after injury. Consistent with these findings, using triple-color immunofluorescence analysis revealed that F4/80+CD80+ M1 macrophages were more abundant than F4/80+CD206+ M2 macrophages on day 3 in mouse wound specimens, and that M2 macrophages were prominently detected in day 6 wounds. For application in forensic practice, we examined macrophage polarization using human wound specimens. The average ratios of CD68+iNOS+ M1 macrophages to CD68+CD163+ M2 macrophages (M1/M2 ratios) were greater than 2.5 for the wounds aged 2–5 days. Out of 11 wounds aged 1–5 days, five samples had the M1/M2 ratios of > 3.0. These observations propose that the M1/M2 ratios of 3.0 would indicate a wound age of 1–5 days as the forensic opinion. This study showed that M1 and M2 macrophages in human skin wound might be a promising marker for wound age determination.

1 October 2020 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
YIYuko Ishida
Yuko Ishida
YKYumi Kuninaka
Yumi Kuninaka
YYYuki Yamamoto
Yuki Yamamoto
MNMizuho Nosaka
Mizuho Nosaka
AKAkihiko Kimura
Akihiko Kimura
TKToshikazu Kondo
Toshikazu Kondo

1 March 2006 in Legal Medicine
Verified
Journal Article
Closed access
YIYuko Ishida
Yuko Ishida
TTTatsunori Takayasu
Tatsunori Takayasu
AKAkihiko Kimura
Akihiko Kimura
THTakahito Hayashi
Takahito Hayashi
NKNobuyuku Kakimoto
Nobuyuku Kakimoto
TKToshikazu Kondo
Toshikazu Kondo

1 December 2020 in International Journal of Cardiology
Verified
Journal Article
Closed access
YKYosuke Katayama
Yosuke Katayama
ATAtsushi Tanaka
Atsushi Tanaka
ATAkira Taruya
Akira Taruya
MKManabu Kashiwagi
Manabu Kashiwagi
TNTsuyoshi Nishiguchi
Tsuyoshi Nishiguchi
TATakashi Akasaka
Takashi Akasaka

Verified
Journal Article
Open access
PDF file
YIYuya Iwahashi
Yuya Iwahashi
YIYuko Ishida
Yuko Ishida
Naofumi MukaidaNaofumi Mukaida
Naofumi Mukaida
TKToshikazu Kondo
Toshikazu Kondo
CX3CL1 and its unique receptor, CX3CR1, are leukocyte migration factors and are involved in the pathogenesis and progression of many inflammatory diseases and malignancies. The CX3CL1-CX3CR1 axis induces a variety of responses, including cell proliferation, migration, invasion, and apoptosis resistance. CX3CL1 is a transmembrane protein, and proteolysis generates a soluble form. The membrane and soluble forms of CX3CL1 exhibit different functions, but both bind to the chemokine receptor CX3CR1. The CX3CL1-CX3CR1 axis is a chemokine system that has attracted attention not only as a therapeutic target but also as a potentially useful diagnostic and prognostic marker for disease. Many studies have reported that the CX3CL1-CX3CR1 axis is involved in disease progression, but more recently there are scattered reports suggesting that it is involved in disease suppression. In this article, we summarize the latest findings on the pathophysiological role of the CX3CL1-CX3CR1 axis, with a particular focus on renal disease, cardiovascular disease, and cancer.